Shell Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-859
Closed -$83K 1410
2022
Q1
$83K Sell
859
-126
-13% -$16.6K ﹤0.01% 1312
2021
Q4
$197K Sell
985
-523
-35% -$123K ﹤0.01% 1214
2021
Q3
$373K Sell
1,508
-65
-4% -$18.6K 0.01% 991
2021
Q2
$651K Buy
1,573
+85
+6% +$33.7K 0.01% 789
2021
Q1
$581K Buy
1,488
+617
+71% +$304K 0.01% 781
2020
Q4
$488K Buy
871
+477
+121% +$302K 0.01% 815
2020
Q3
$275K Hold
394
0.01% 938
2020
Q2
$311K Sell
394
-6
-2% -$4.52K 0.01% 878
2020
Q1
$238K Sell
400
-6
-1% -$5.85K 0.01% 955
2019
Q4
$462K Sell
406
-11
-3% -$12K 0.01% 918
2019
Q3
$496K Sell
417
-3
-0.7% -$4.58K 0.01% 893
2019
Q2
$693K Sell
420
-10
-2% -$17.3K 0.02% 743
2019
Q1
$876K Buy
430
+46
+12% +$81K 0.02% 639
2018
Q4
$494K Sell
384
-31
-7% -$47.6K 0.01% 848
2018
Q3
$785K Hold
415
0.02% 800
2018
Q2
$844K Sell
415
-22
-5% -$50.1K 0.02% 755
2018
Q1
$967K Hold
437
0.02% 692
2017
Q4
$1.01M Buy
+437
New +$887K 0.02% 671

Other funds holding BLUE

Shell Asset Management's BLUE Position: Q2 2022 in Review

Shell Asset Management sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 859 shares — an estimated $83K sold.

Shell Asset Management first reported a position in BLUE in Q4 2017 and held it in 18 quarters. The position peaked at $1.01M in Q4 2017. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • Shell Asset Management reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • Shell Asset Management sold 859 bluebird bio shares in Q2 2022, an estimated $83K.
  • Shell Asset Management first reported a position in bluebird bio in Q4 2017 and held it in 18 quarters.
  • Shell Asset Management's bluebird bio position peaked at $1.01M in Q4 2017.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Shell Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.